|
1.
|
|
9 p, 244.3 KB |
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials
/
Taipale, Heidi (University of Eastern Finland) ;
Schneider-Thoma, Johannes (Technical University of Munich) ;
Pinzón-Espinosa, Justo (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Radua, Joaquim (King's College London. Institute of Psychiatry, Psychology & Neuroscience) ;
Efthimiou, Orestis (Department of Psychiatry, University of Oxford) ;
Vinkers, Christiaan H. (Department of Psychiatry. Vrije Universiteit Amsterdam) ;
Mittendorfer-Rutz, Ellenor (Karolinska Institutet (Estocolm, Suècia). Department of Clinical Neuroscience) ;
Cardoner, N. (Narcís) (Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal) ;
Pintor Pérez, Luis (Hospital Clínic i Provincial de Barcelona) ;
Tanskanen, Antti (Karolinska Institutet (Estocolm, Suècia). Department of Clinical Neuroscience) ;
Tomlinson, Anneka (Warneford Hospital) ;
Fusar-Poli, Paolo (South London and Maudsley NHS Foundation Trust) ;
Cipriani, Andrea (Warneford Hospital) ;
Vieta, Eduard (Hospital Clínic i Provincial de Barcelona) ;
Leucht, Stefan (Department of Psychiatry and Psychotherapy. Technical University of Munich) ;
Tiihonen, Jari (Stockholm City Council) ;
Luykx, Jurjen J. (GGNet Mental Health (Holanda))
This cohort study quantifies the proportion of real-world individuals with schizophrenia spectrum disorders who would be ineligible for participation in randomized clinical trials and explores whether clinical outcomes differ between eligible and ineligible individuals. [...]
2022 -  10.1001/jamapsychiatry.2021.3990
JAMA Psychiatry, Vol. 79 (january 2022) , p. 1-9
|
|
|
2.
|
|
11 p, 713.9 KB |
Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis
/
Modinos, Gemma (King's College London. Institute of Psychiatry, Psychology & Neuroscience) ;
Kempton, Matthew J. (National Institute for Health Research, Biomedical Research Centre, London, United Kingdom) ;
Tognin, Stefania (King's College London. Institute of Psychiatry, Psychology & Neuroscience) ;
Calem, Maria (King's College London. Institute of Psychiatry, Psychology & Neuroscience) ;
Porffy, Lilla (King's College London. Institute of Psychiatry, Psychology & Neuroscience) ;
Antoniades, Mathilde (King's College London. Institute of Psychiatry, Psychology & Neuroscience) ;
Mason, Ava (King's College London. Institute of Psychiatry, Psychology & Neuroscience) ;
Azis, Matilda (King's College London. Institute of Psychiatry, Psychology & Neuroscience) ;
Allen, Paul (Department of Psychology, University of Roehampton, London, United Kingdom) ;
Nelson, Barnaby (Centre for Youth Mental Health, University of Melbourne, Melbourne, Victoria, Australia) ;
McGorry, Patrick (Centre for Youth Mental Health, University of Melbourne, Melbourne, Victoria, Australia) ;
Pantelis, Christos (Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark) ;
Riecher-Rössler, Anita (University Hospital Basel (Basilea, Suïssa)) ;
Borgwardt, Stefan (University Hospital Basel (Basilea, Suïssa)) ;
Bressan, Rodrigo Affonseca (LiNC-Lab Interdisciplinar Neurociências Clínicas, Depto Psiquiatria, Escola Paulista de Medicina, Universidade Federal de São Paulo-UNIFESP, São Paulo, Brazil) ;
Barrantes-Vidal, Neus (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ;
Krebs, Marie-Odile (University of Paris, GHU-Paris, Sainte-Anne, C'JAAD, Hospitalo-Universitaire Department SHU, Inserm U1266, Institut de Psychiatrie (CNRS 3557), Paris, France) ;
Nordentoft, Merete (Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, Mental Health Center Glostrup, Mental Health Services in the Capital Region of Copenhagen, University of Copenhagen, Copenhagen, Denmark) ;
Glenthøj, Birte (University of Copenhagen. Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research) ;
Ruhrmann, Stephan (Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany) ;
Sachs, Gabriele (Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria) ;
Rutten, Bart (School for Mental Health and Neuroscience, Department of Psychiatry and Neuropsychology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands) ;
van Os, Jim (Universiteit Utrecht) ;
de Haan, Lieuwe (Early Psychosis Department, Amsterdam UMC, Amsterdam, the Netherlands) ;
Velthorst, Eva (Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York) ;
van der Gaag, Mark (Parnassia Psychiatric Institute, Department of Psychosis Research, The Hague, the Netherlands) ;
Valmaggia, Lucia (Institute of Psychiatry, Psychology & Neuroscience, Department of Psychology, King's College London, London, United Kingdom) ;
McGuire, Philip (South London and Maudsley National Health Service Foundation Trust, London, United Kingdom)
This case-control study analyzes emotion recognition and neuroimaging data as well as clinical and functional outcomes for individuals at risk for transition to psychosis and those without psychiatric or neurological disorders. [...]
2019 - 10.1001/jamapsychiatry.2019.3501
JAMA Psychiatry, Vol. 77 (november 2019) , p. 190-200
|
|
guest ::
email alert
or subscribe to the 
RSS feed.
